For those who are with HER2-positive breast cancer, their health specialist may recommend medicines that only affect HER2-positive unhealthy cells. These anti-HER2 medicines inhibit HER2 to halt the growth of unhealthy cells.
Trastuzumab deruxtecan (Enhertu):
Trastuzumab deruxtecan is supplied under the trade name Enhertu and in the strength of 100 mg vials or injections. Enhertu 100 mg injection is approved for treating patients with metastatic HER2 +Ve breast cancer who have previously received two or more HER2-targeted therapies. This HER2-targeted therapy is a combination of a medication that is identical to trastuzumab, named a biosimilar, linked to a tiny amount of strong chemo. The trastuzumab biosimilar carries the chemo to the HER2 +Ve unhealthy cells, so it can kill unhealthy cells and limit the destruction to healthy cells. It is given by vein every 3 weeks. If someone is looking to buy enhertu online in India or wants to know the information related to sourcing, procurement, and availability, kindly connect with THE INDIAN PHARMA (TIP).
Trastuzumab (Herceptin):
Trastuzumab is approved to treat HER2-positive breast cancer. At present, patients with stage I-III breast cancer generally receive a trastuzumab-based treatment, often including a conjunction of trastuzumab and chemotherapy, followed by the completion of 12 months of adjuvant trastuzumab. The medicine Trastuzumab is also an inevitable part of treatment for patients with metastatic HER2-positive breast cancer.
Pertuzumab (Perjeta):
This medicine is approved as part of treatment for breast cancer in conjunction with drug trastuzumab and chemotherapy. It is also used along with trastuzumab and chemotherapy for those with metastatic HER2-positive breast cancer.
Pertuzumab, trastuzumab, and hyaluronidase–zzxf (Phesgo):
This combination medicine, which contains pertuzumab, trastuzumab, and hyaluronidase-zzxf in a single dose, is used for patients with early-stage HER2 +ve breast cancer. It may be given together with chemo. It is given by injection under the skin and can be administered either at a treatment center or at home by a health specialist.
Ado-trastuzumab emtansine or T-DM1 (Kadcyla):
This medicine is a combination of trastuzumab linked to a sort of chemotherapy. This enables the drug to deliver chemo into the unhealthy cell while scaling down the chemo received by healthy cells. Kadcyla is approved for the treatment of patients who receive trastuzumab along with chemotherapy followed by surgery and who are found to still have unhealthy cells in the breast at the time of surgery.
Lapatinib (Tykerb):
Lapatinib is widely used for the treatment of metastatic HER2 -positive breast cancer. It may be given along with letrozole or capecitabine.
Neratinib (Nerlynx):
Neratinib is and oral medicine approved as a treatment for higher-risk HER2 +Ve, early-stage breast cancer. It is also used for treating metastatic disease. It is taken for a year, and initiated after those who have finished 12 months of trastuzumab.
Tucatinib (Tukysa):
Tucatinib is approved to treat advanced unresectable or metastatic HER2 +ve breast cancer, including cancer that has progressed to the brain, in those individuals who have previously received single or more HER2-targeted therapy. Tukysa150 mg tablets are the standard dosage that can be taken orally twice daily. This medicine is a tyrosine kinase inhibitor (TKI) and is designed to turn off HER2. This medicinal product can be obtained after a valid prescription only from your treating health specialist/physician. If someone is looking for tukysa supplier in India, we can help facilitate the supply of this medicine at your location.
Where To Buy These Breast Cancer Medicines:
Service providers like THE INDIAN PHARMA, that are highly experienced in supplying life-saving breast cancer medicines in India and abroad can be considered for the most reliable procurement. Contact us at TOLL-FREE: 1800-889-1064 or Call/WhatsApp: +91 9310090915.
